Jasper Therapeutics Target Price

Analysts' average 12-month price target for Jasper Therapeutics is $2.

Get informed when a big investor buys or sells

+ Follow

Share Price

$13.68

Average Target Price

$2.00

85.4% downside

1 analysts in the last 4 months

High: $2 | Low: $2

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-08-12	Piper SandlerBiren Amin	$2	85.4% downside
2026-05-15	RBC Capital	$3	78.1% downside
2025-01-09	RBC CapitalGregory Renza	$48	250.9% upside
2024-12-05	BMO CapitalEtzer Darout	$63	360.5% upside
2024-05-06	H.C. WainwrightEmily Bodnar	$65	375.1% upside
2024-04-03	Evercore ISIGavin Clark-Gartner	$65	375.1% upside
2023-02-07	Cantor Fitzgerald	$6	56.1% downside
2023-01-11	Credit Suisse	$3	78.1% downside

Jasper Therapeutics (JSPR) FAQ

As of the most recent data, JSPR shows a target price of $2. Scroll down for historical charts and peer comparison views.

If Jasper Therapeutics moved to the average analyst target of $2, shares would be roughly 85.4% lower than $13.68. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of Jasper Therapeutics's earnings trajectory.

Besides this target price page, Stockcircle has Jasper Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $2) with ownership activity and broader fundamentals.